$ASMB
Assembly Biosciences Inc

2016 Q3 Form 10-Q Financial Statement

#000114420416132547 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.850M $2.490M
YoY Change 14.46% -66.26%
% of Gross Profit
Research & Development $8.833M $4.630M
YoY Change 90.77% 26.09%
% of Gross Profit
Depreciation & Amortization $18.00K $18.00K
YoY Change 0.0% 1023.6%
% of Gross Profit
Operating Expenses $8.833M $4.630M
YoY Change 90.77% 26.09%
Operating Profit -$11.68M -$7.122M
YoY Change 63.98% -35.58%
Interest Expense $100.0K $500.0K
YoY Change -80.0% 1150.0%
% of Operating Profit
Other Income/Expense, Net $504.3K
YoY Change 1333.38%
Pretax Income -$11.57M -$6.620M
YoY Change 74.84% -39.93%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$11.57M -$6.618M
YoY Change 74.89% -39.95%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$671.5K -$384.7K
COMMON SHARES
Basic Shares Outstanding 17.23M shares 17.19M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.60M $65.80M
YoY Change -10.94% 267.6%
Cash & Equivalents $23.79M $36.40M
Short-Term Investments $34.90M $29.40M
Other Short-Term Assets $600.0K $705.3K
YoY Change -14.93% 379.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $59.30M $66.50M
YoY Change -10.83% 267.83%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $156.5K
YoY Change -36.1% 359.11%
Goodwill $12.64M
YoY Change 0.0%
Intangibles $29.00M
YoY Change -3.77%
Long-Term Investments $8.100M $31.40M
YoY Change -74.2%
Other Assets
YoY Change
Total Long-Term Assets $49.87M $73.15M
YoY Change -31.82% 72.88%
TOTAL ASSETS
Total Short-Term Assets $59.30M $66.50M
Total Long-Term Assets $49.87M $73.15M
Total Assets $109.1M $139.7M
YoY Change -21.88% 131.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.800M $1.500M
YoY Change 153.33% 50.0%
Accrued Expenses $3.600M $1.187M
YoY Change 203.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.500M $2.652M
YoY Change 182.85% 152.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $11.60M $11.60M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.500M $2.652M
Total Long-Term Liabilities $11.60M $11.60M
Total Liabilities $19.10M $14.25M
YoY Change 34.02% 8.03%
SHAREHOLDERS EQUITY
Retained Earnings -$156.2M
YoY Change 20.83%
Common Stock $17.23K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $90.00M $125.4M
YoY Change
Total Liabilities & Shareholders Equity $109.1M $139.7M
YoY Change -21.88% 131.24%

Cashflow Statement

Concept 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$11.57M -$6.618M
YoY Change 74.89% -39.95%
Depreciation, Depletion And Amortization $18.00K $18.00K
YoY Change 0.0% 1023.6%
Cash From Operating Activities -$7.860M -$5.180M
YoY Change 51.74% 33.85%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $11.35M -$12.19M
YoY Change -193.11% -2490.2%
Cash From Investing Activities $11.32M -$12.19M
YoY Change -192.86% -2587.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 260.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -7.860M -5.180M
Cash From Investing Activities 11.32M -12.19M
Cash From Financing Activities 0.000 260.0K
Net Change In Cash 3.460M -17.11M
YoY Change -120.22% 406.21%
FREE CASH FLOW
Cash From Operating Activities -$7.860M -$5.180M
Capital Expenditures -$40.00K $0.00
Free Cash Flow -$7.820M -$5.180M
YoY Change 50.97% 34.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
34851387 USD
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
40556652 USD
CY2016Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7900260 USD
CY2015Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
23392129 USD
CY2016Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
49872193 USD
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
65376032 USD
CY2016Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11600000 USD
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32729858 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21093435 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15189395 shares
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1609 USD
CY2015Q3 us-gaap Interest Income Other
InterestIncomeOther
502684 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
270779 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
252050 USD
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-836568 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-821585 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
33410207 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
21479349 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-33410207 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21479349 USD
us-gaap Interest Income Other
InterestIncomeOther
1313407 USD
us-gaap Interest Income Other
InterestIncomeOther
772183 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
773792 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8939573 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8347013 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.90
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.36
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17225625 shares
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-618075 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8833027 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4630148 USD
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11678925 USD
CY2015Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7122226 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11678925 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7122226 USD
CY2016Q3 us-gaap Interest Income Other
InterestIncomeOther
378381 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-11574117 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2845898 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2492078 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17205863 shares
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11571323 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6871592 USD
CY2016Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-273573 USD
CY2015Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1609 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
633058 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
386269 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
273573 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1609 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
618075 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1609 USD
us-gaap Depreciation
Depreciation
55250 USD
us-gaap Depreciation
Depreciation
47949 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4033036 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6355453 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23842420 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13242134 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35094 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47991 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4033036 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20528982 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-61016749 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
81569257 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3313438 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7310374 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29091113 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36401487 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2474266 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
556738 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1605078 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1140024 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
580011 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7951256 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
63668536 USD
us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-14983 USD
us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-387878 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
81014989 USD
asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
0 USD
asmb Accrued Offering Cost Related To Issuance Of Common Stock
AccruedOfferingCostRelatedToIssuanceOfCommonStock
554268 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28515332 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2699778 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-8186 USD
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-55121 USD
asmb Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0 USD
asmb Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
88 USD
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
-14983 USD
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4394110 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3301333 shares
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
42751647 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
10117141 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
26357649 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
36474790 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
45335 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
818129 USD
CY2016Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
863464 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
298050 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
262956 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
169597 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114347 USD
CY2015Q3 us-gaap Depreciation
Depreciation
18000 USD
CY2016Q3 us-gaap Depreciation
Depreciation
18000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2477812 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1628975 USD
CY2016Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
0 USD
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
106777 USD
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
182752 USD
CY2016Q3 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
713888 USD
CY2015Q4 asmb Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
120700 USD
CY2016Q3 asmb Accured General And Administrative Expenses Current
AccuredGeneralAndAdministrativeExpensesCurrent
452582 USD
CY2015Q4 asmb Accured General And Administrative Expenses Current
AccuredGeneralAndAdministrativeExpensesCurrent
0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6355453 USD
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
318000 USD
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
159000 USD
CY2016Q3 asmb Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
1117796 USD
CY2016Q3 asmb Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
2722769 USD
CY2016Q3 asmb Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
1233560 USD
CY2016Q3 asmb Future Stock Based Compensation Expense Year Four
FutureStockBasedCompensationExpenseYearFour
488828 USD
CY2016Q3 asmb Futurestockbasedcompensationexpenseyearfive
Futurestockbasedcompensationexpenseyearfive
100085 USD
CY2016Q3 asmb Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
5663038 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4033036 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1055043 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1149429 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1100000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
456000 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17225554 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17225554 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17225662 shares
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5700000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
5958 USD
asmb Operating Lease Expiration Month And Year
OperatingLeaseExpirationMonthAndYear
2021-06
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.45
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
43588215 USD
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
26896 USD
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
863464 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
64770366 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
821585 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
63948781 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Significant estimates inherent in the preparation of the accompanying financial statements include recoverability and useful lives (indefinite) of intangible assets, assessment of impairment of goodwill, and the fair value of stock options and warrants granted to employees, consultants, directors, investors, licensors, placement agents and underwriters.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company&#8217;s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates and assumptions.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D

Files In Submission

Name View Source Status
0001144204-16-132547-index-headers.html Edgar Link pending
0001144204-16-132547-index.html Edgar Link pending
0001144204-16-132547.txt Edgar Link pending
0001144204-16-132547-xbrl.zip Edgar Link pending
asmb-20160930.xml Edgar Link completed
asmb-20160930.xsd Edgar Link pending
asmb-20160930_cal.xml Edgar Link unprocessable
asmb-20160930_def.xml Edgar Link unprocessable
asmb-20160930_lab.xml Edgar Link unprocessable
asmb-20160930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451818_10q.htm Edgar Link pending
v451818_ex10-1.htm Edgar Link pending
v451818_ex31-1.htm Edgar Link pending
v451818_ex31-2.htm Edgar Link pending
v451818_ex32-1.htm Edgar Link pending
v451818_ex32-2.htm Edgar Link pending